Northern Trust’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,700
| Closed | -$45K | – | 4857 |
|
|
2022
Q1 | $45K | Hold |
5,700
| – | – | ﹤0.01% | 4556 |
|
|
2021
Q4 | $94K | Hold |
5,700
| – | – | ﹤0.01% | 4443 |
|
|
2021
Q3 | $144K | Hold |
5,700
| – | – | ﹤0.01% | 4305 |
|
|
2021
Q2 | $190K | Hold |
5,700
| – | – | ﹤0.01% | 4178 |
|
|
2021
Q1 | $247K | Buy |
5,700
+1,987
| +54% | +$83.2K | ﹤0.01% | 4035 |
|
|
2020
Q4 | $68K | Buy |
3,713
+316
| +9% | +$6.18K | ﹤0.01% | 4192 |
|
|
2020
Q3 | $193K | Buy |
3,397
+517
| +18% | +$24.1K | ﹤0.01% | 3830 |
|
|
2020
Q2 | $86K | Buy |
2,880
+1,387
| +93% | +$39.2K | ﹤0.01% | 3953 |
|
|
2020
Q1 | $29K | Buy |
1,493
+1,029
| +222% | +$34.5K | ﹤0.01% | 4039 |
|
|
2019
Q4 | $25K | Hold |
464
| – | – | ﹤0.01% | 4141 |
|
|
2019
Q3 | $25K | Hold |
464
| – | – | ﹤0.01% | 4140 |
|
|
2019
Q2 | $53K | Hold |
464
| – | – | ﹤0.01% | 4076 |
|
|
2019
Q1 | $78K | Sell |
464
-333
| -42% | -$40.8K | ﹤0.01% | 3974 |
|
|
2018
Q4 | $59K | Hold |
797
| – | – | ﹤0.01% | 4022 |
|
|
2018
Q3 | $114K | Sell |
797
-36
| -4% | -$5.27K | ﹤0.01% | 4003 |
|
|
2018
Q2 | $119K | Buy |
+833
| New | +$125K | ﹤0.01% | 3980 |
|
|
2018
Q1 | – | Sell |
-113
| Closed | -$41K | – | 4291 |
|
|
2017
Q4 | $41K | Hold |
113
| – | – | ﹤0.01% | 4093 |
|
|
2017
Q3 | $65K | Hold |
113
| – | – | ﹤0.01% | 4030 |
|
|
2017
Q2 | $112K | Buy |
113
+97
| +606% | +$100K | ﹤0.01% | 3950 |
|
|
2017
Q1 | $22K | Buy |
+16
| New | +$19.3K | ﹤0.01% | 4146 |
|
Other funds holding ZSAN
Northern Trust's ZSAN Position: Q2 2022 in Review
Northern Trust sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 5,700 shares — an estimated $45K sold.
Northern Trust first reported a position in ZSAN in Q1 2017 and held it in 20 quarters. The position peaked at $247K in Q1 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.
- Northern Trust reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
- Northern Trust sold 5,700 Zosano Pharma Corporation shares in Q2 2022, an estimated $45K.
- Northern Trust first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 20 quarters.
- Northern Trust's Zosano Pharma Corporation position peaked at $247K in Q1 2021.
- 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.
Based on Northern Trust's 13F filing for Q2 2022, filed 12 Aug 2022.